XML 26 R17.htm IDEA: XBRL DOCUMENT v3.23.2
STOCKHOLDERS' EQUITY
6 Months Ended
Jun. 30, 2023
STOCKHOLDERS' EQUITY  
STOCKHOLDERS' EQUITY

NOTE H – STOCKHOLDERS’ EQUITY

Accumulated Other Comprehensive Income

Components of accumulated other comprehensive income were as follows:

    

June 30

    

December 31

    

2023

    

2022

 

(in thousands)

Pre-tax amounts:

Unrecognized net periodic benefit credit

$

8,622

$

9,287

Interest rate swap

2,955

3,526

Foreign currency translation

 

(2,731)

 

(3,247)

Total

$

8,846

$

9,566

After-tax amounts:

Unrecognized net periodic benefit credit

$

6,402

$

6,896

Interest rate swap

2,183

2,604

Foreign currency translation

 

(2,016)

 

(2,397)

Total

$

6,569

$

7,103

The following is a summary of the changes in accumulated other comprehensive income, net of tax, by component for the six months ended June 30, 2023 and 2022:

Unrecognized

Interest

Foreign

Net Periodic

Rate

Currency

    

Total

    

Benefit Credit

    

Swap

    

Translation

 

(in thousands)

Balances at December 31, 2022

$

7,103

$

6,896

$

2,604

$

(2,397)

Other comprehensive income (loss) before reclassifications

 

(40)

 

(421)

 

381

Amounts reclassified from accumulated other comprehensive income

 

(494)

 

(494)

 

Net current-period other comprehensive income (loss)

 

(534)

 

(494)

(421)

 

381

Balances at June 30, 2023

$

6,569

$

6,402

$

2,183

$

(2,016)

Balances at December 31, 2021

$

3,699

$

4,160

$

309

$

(770)

Other comprehensive income (loss) before reclassifications

1,556

1,802

(246)

Amounts reclassified from accumulated other comprehensive income

(281)

(281)

Net current-period other comprehensive income (loss)

1,275

(281)

1,802

(246)

Balances at June 30, 2022

$

4,974

$

3,879

$

2,111

$

(1,016)

The following is a summary of the significant reclassifications out of accumulated other comprehensive income by component:

Unrecognized Net Periodic

Benefit Credit

 

Six Months Ended June 30

    

2023

    

2022

 

(in thousands)

 

Amortization of net actuarial gain, pre-tax(1)

$

665

$

378

Tax expense

(171)

 

(97)

Total, net of tax

$

494

$

281

(1)Included in the computation of net periodic benefit credit of the Company’s supplemental benefit plan (“SBP”) and postretirement health benefit plan.

Dividends on Common Stock

The following table is a summary of dividends declared during the applicable quarter:

2023

2022

    

Per Share

    

Amount

    

Per Share

    

Amount

 

(in thousands, except per share data)

First quarter

$

0.12

$

2,915

$

0.08

$

1,978

Second quarter

$

0.12

$

2,894

$

0.12

$

2,949

On July 26, 2023, the Company announced its Board of Directors declared a dividend of $0.12 per share to stockholders of record as of August 9, 2023.

Treasury Stock

The Company has a program to repurchase its common stock in the open market or in privately negotiated transactions (the “share repurchase program”). The share repurchase program has no expiration date but may be terminated at any time at the Board of Directors’ discretion. Repurchases may be made using the Company’s cash reserves or other available sources.

As of December 31, 2022, the Company had $26.5 million available for repurchases of its common stock in total under the share repurchase program. In February 2023, the Board of Directors reauthorized the share repurchase program and increased the total amount available for purchases of the Company’s common stock under the program to $125.0 million. In March 2023, the Company entered into a 10b5-1 agreement allowing for stock repurchases during the closed trading window extending from March 16, 2023 to May 2, 2023.

During the six months ended June 30, 2023, the Company repurchased 453,296 shares for an aggregate cost of $41.2 million, including 305,751 shares for an aggregate cost of $28.0 million under the 10b5-1 agreement. The Company had $83.8 million remaining under its share repurchase program as of June 30, 2023.